Search Results

Clinical Predictors of Relapse after Treatment of Primary Gastrointestinal Cytomegalovirus Disease in Solid Organ Transplant Recipients

Authors: Eid, A. J.; Arthurs, S. K.; Deziel, P. J.; Wilhelm, M. P.; Razonable, R. R.

Source: American Journal of Transplantation, Volume 10, Number 1, January 2010 , pp. 157-161(5)

Publisher: Blackwell Publishing

Clinical virology of cytomegalovirus infection following hematopoietic transplantation

Authors: Solano, Carlos; Navarro, David

Source: Future Virology, Volume 5, Number 1, January 2010 , pp. 111-124(14)

Publisher: Future Medicine

Treatment Strategies to Minimize or Prevent Chronic Allograft Dysfunction in Pediatric Renal Transplant Recipients: An Overview

Authors: Höcker, Britta; Tönshoff, Burkhard

Source: Pediatric Drugs, Volume 11, Number 6, 1 December 2009 , pp. 381-396(16)

Publisher: Adis International

Late-onset CMV disease following CMV prophylaxis

Authors: Donnelly, C.; Kennedy, F.; Keane, C.; Schaffer, K.; McCormick, P.

Source: Irish Journal of Medical Science, Volume 178, Number 3, September 2009 , pp. 333-336(4)

Publisher: Springer

Preemptive therapy is not adequate for prevention of cytomegalovirus disease in pancreas-kidney transplant recipients

Authors: López-Medrano, F.; Rueda, B.; Lizasoain, M.; Juan, R. San; Folgueira, D.; Andrés, A.; Morales, J. M.; Jiménez, C.; Meneu, J. C.; Aguado, J. M.

Source: Transplant Infectious Disease, Volume 11, Number 5, October 2009 , pp. 400-404(5)

Publisher: Blackwell Publishing

Infectious complications associated with alemtuzumab use for allogeneic hematopoietic stem cell transplantation: comparison with anti-thymocyte globulin

Authors: Park, S.H.; Choi, S.-M.; Lee, D.-G.; Choi, J.-H.; Yoo, J.-H.; Kim, S.-H.; Kim, H.-J.; Cho, S.-G.; Eom, K.-S.; Lee, J.-W.; Min, W.-S.; Shin, W.-S.; Kim, C.-C.

Source: Transplant Infectious Disease, Volume 11, Number 5, October 2009 , pp. 413-423(11)

Publisher: Blackwell Publishing

A new strategy of delayed long-term prophylaxis could prevent cytomegalovirus disease in (D+/R−) solid organ transplant recipients

Authors: Juan, R. San; Yebra, M.; Lumbreras, C.; López-Medrano, F.; Lizasoain, M.; Meneu, J.C.; Delgado, J.; Andrés, A.; Aguado, J.M.

Source: Clinical Transplantation, Volume 23, Number 5, September/October 2009 , pp. 666-671(6)

Publisher: Blackwell Publishing

CMV infection, diagnosis and antiviral strategies after liver transplantation

Author: Lautenschlager, Irmeli

Source: Transplant International, Volume 22, Number 11, November 2009 , pp. 1031-1040(10)

Publisher: Blackwell Publishing

Cytomegalovirus infection following renal transplantation in patients administered low-dose rituximab induction therapy

Authors: Nishida, Hayato; Ishida, Hideki; Tanaka, Toshiaki; Amano, Hiroyuki; Omoto, Kazuya; Shirakawa, Hiroki; Shimizu, Tomokazu; Iida, Shoichi; Toki, Daisuke; Yamaguchi, Yutaka; Tanabe, Kazunari

Source: Transplant International, Volume 22, Number 10, October 2009 , pp. 961-969(9)

Publisher: Blackwell Publishing

Long-term outcomes of cytomegalovirus infection and disease after lung or heart-lung transplantation with a delayed ganciclovir regimen

Authors: Thomas, Lora D.; Milstone, Aaron P.; Miller, Geraldine G.; Loyd, James E.; Stephen Dummer, J.

Source: Clinical Transplantation, Volume 23, Number 4, August/September 2009 , pp. 476-483(8)

Publisher: Blackwell Publishing

Valganciclovir in Adult Solid Organ Transplant Recipients: Pharmacokinetic and Pharmacodynamic Characteristics and Clinical Interpretation of Plasma Concentration Measurements

Authors: Perrottet, Nancy; Decosterd, Laurent A.; Meylan, Pascal; Pascual, Manuel; Biollaz, Jerome; Buclin, Thierry

Source: Clinical Pharmacokinetics, Volume 48, Number 6, 6 June 2009 , pp. 399-418(20)

Publisher: Adis International

Population Pharmacokinetics of Ganciclovir Following Administration of Valganciclovir in Paediatric Renal Transplant Patients

Authors: Zhao, Wei; Baudouin, Véronique; Zhang, Daolun; Deschênes, Georges; >Chantal Le Guellec,; Jacqz-Aigrain, Evelyne

Source: Clinical Pharmacokinetics, Volume 48, Number 5, 5 May 2009 , pp. 321-328(8)

Publisher: Adis International

Extended CMV prophylaxis pays off in renal transplantation

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 581, 2009-06-27 , pp. 4-4(1)

Publisher: Adis International

Oral ganciclovir versus valganciclovir for cytomegalovirus prophylaxis in high-risk liver transplant recipients

Authors: Brady, R.L.; Green, K.; Frei, C.; Maxwell, P.

Source: Transplant Infectious Disease, Volume 11, Number 2, April 2009 , pp. 106-111(6)

Publisher: Blackwell Publishing

A Multicenter Study of Valganciclovir Prophylaxis up to Day 120 in CMV-Seropositive Lung Transplant Recipients

Authors: Monforte, V.; Lopez, C.; Santos, F.; Zurbano, F.; de la Torre, M.; Sole, A.; Gavalda, J.; Ussetti, P.; Lama, R.; Cifrian, J.; Borro, J. M.; Pastor, A.; Len, O.; Bravo, C.; Roman, A.

Source: American Journal of Transplantation, Volume 9, Number 5, May 2009 , pp. 1134-1141(8)

Publisher: Blackwell Publishing

Cell-Mediated Immunity to Predict Cytomegalovirus Disease in High-Risk Solid Organ Transplant Recipients

Authors: Kumar, D.; Chernenko, S.; Moussa, G.; Cobos, I.; Manuel, O.; Preiksaitis, J.; Venkataraman, S.; Humar, A.

Source: American Journal of Transplantation, Volume 9, Number 5, May 2009 , pp. 1214-1222(9)

Publisher: Blackwell Publishing

Prospective follow-up of primary CMV infections after 6 months of valganciclovir prophylaxis in renal transplant recipients

Authors: Helanter, Ilkka; Lautenschlager, Irmeli; Koskinen, Petri

Source: Nephrology Dialysis Transplantation, Volume 24, Number 1, 20 January 2009 , pp. 316-320(5)

Publisher: Oxford University Press

Valganciclovir Dosing According to Body Surface Area and Renal Function in Pediatric Solid Organ Transplant Recipients

Authors: Vaudry, W.; Ettenger, R.; Jara, P.; Varela-Fascinetto, G.; Bouw, M. R.; Ives, J.; Walker, R.

Source: American Journal of Transplantation, Volume 9, Number 3, March 2009 , pp. 636-643(8)

Publisher: Blackwell Publishing

Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation

Authors: Cummins, N.W.; Deziel, P.J.; Abraham, R.S.; Razonable, R.R.

Source: Transplant Infectious Disease, Volume 11, Number 1, February 2009 , pp. 20-27(8)

Publisher: Blackwell Publishing

Impact of the complement lectin pathway on cytomegalovirus disease early after kidney transplantation

Authors: Sagedal, Solbjrg; Thiel, Steffen; Hansen, Troels Krarup; Mollnes, Tom Eirik; Rollag, Halvor; Hartmann, Anders

Source: Nephrology Dialysis Transplantation, Volume 23, Number 12, 30 December 2008 , pp. 4054-4060(7)

Publisher: Oxford University Press